Twist Bioscience Corporation (TWST) FY2026 Q3 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Twist Bioscience Corporation (TWST) FY2026 Q3 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$120.26 MLiabilities$226.70 MNon-current liabilities$106.44 MEquity$445.74 MGross equity(calculated)$1.88 BCurrent assets$321.30 MAssets$672.44 MNon-current assets$351.14 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netPrepaid expenses and other current assetsShort-term investmentsInventoriesProperty and equipment, netGoodwillOperating lease right-of-use assetsInvestment in equity securitiesIntangible assets, netOther non-current assetsRestricted cash, non-currentAccrued expenses and other current liabilitiesAccrued compensationAccounts payableCurrent portion of operating lease liabilityOperating lease liability, net of current portionLiability related to the sale of future revenueOther non-current liabilitiesAdditional paid-in capitalCommon stock, $0.00001 par value —200,000 and 200,000 shares authorized at June 30, 2026 and September 30, 2025, respectively; 62,674 and 60,632 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$59.70 MCurrent liabilitiesCurrent liabilities$120.26 MAccrued compensationAccrued compensation$34.88 MLiabilitiesLiabilities$226.70 MAccounts payableAccounts payable$17.04 MCurrent portion of operating lease liabilityCurrent portion of operating lease liability$8.63 MNon-current liabilitiesNon-current liabilities$106.44 MOperating lease liability, net of current portionOperating lease liability, net of current portion$84.96 MEquityEquity$445.74 MLiability related to the sale of future revenueLiability related to the sale of future revenue$15.00 MOther non-current liabilitiesOther non-current liabilities$6.48 MGross equity (calculated)Gross equity(calculated)$1.88 BCurrent assetsCurrent assets$321.30 MCash and cash equivalentsCash and cash equivalents$117.44 MAccounts receivable, netAccounts receivable, net$65.06 MAssetsAssets$672.44 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$54.24 MShort-term investmentsShort-term investments$49.40 MInventoriesInventories$35.16 MProperty and equipment, netProperty and equipment, net$111.89 MNon-current assetsNon-current assets$351.14 MGoodwillGoodwill$82.20 MOperating lease right-of-use assetsOperating lease right-of-use assets$68.74 MInvestment in equity securitiesInvestment in equity securities$68.09 MAdditional paid-in capitalAdditional paid-in capital$1.88 BIntangible assets, netIntangible assets, net$12.73 MOther non-current assetsOther non-current assets$5.38 MRestricted cash, non-currentRestricted cash, non-current$2.13 MCommon stock, $0.00001 par value —200,000 and 200,000 shares authorized at June 30, 2026 and September 30, 2025, respectively; 62,674 and 60,632 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectivelyCommon stock$1.00 KAccumulated deficitAccumulated deficit−$1.43 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$655.00 K
Chart details

Twist Bioscience Corporation (TWST) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
672,437,000 US dollars
Current assets
321,295,000 US dollars
Non-current assets
351,142,000 US dollars
Liabilities
226,698,000 US dollars
Current liabilities
120,255,000 US dollars
Non-current liabilities
106,443,000 US dollars
Equity
445,739,000 US dollars
Cash and cash equivalents
117,436,000 US dollars
Accounts receivable, net
65,055,000 US dollars
Prepaid expenses and other current assets
54,239,000 US dollars
Short-term investments
49,403,000 US dollars
Inventories
35,162,000 US dollars
Property and equipment, net
111,888,000 US dollars
Goodwill
82,195,000 US dollars
Operating lease right-of-use assets
68,736,000 US dollars
Investment in equity securities
68,087,000 US dollars
Intangible assets, net
12,730,000 US dollars
Other non-current assets
5,376,000 US dollars
Restricted cash, non-current
2,130,000 US dollars
Accrued expenses and other current liabilities
59,703,000 US dollars
Accrued compensation
34,879,000 US dollars
Accounts payable
17,043,000 US dollars
Current portion of operating lease liability
8,630,000 US dollars
Operating lease liability, net of current portion
84,960,000 US dollars
Liability related to the sale of future revenue
15,000,000 US dollars
Other non-current liabilities
6,483,000 US dollars
Additional paid-in capital
1,875,550,000 US dollars
Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at June 30, 2026 and September 30, 2025, respectively; 62,674 and 60,632 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively
1,000 US dollars
Accumulated deficit
negative 1,429,157,000 US dollars
Accumulated other comprehensive loss
negative 655,000 US dollars
Gross equity (calculated)
1,875,551,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Twist Bioscience Corporation (TWST) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!